logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (vi) New inpatient clients, primary drug distribution by age (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opioids6.317.151.661.161.559.855.334.743088
Cocaine1.83.15.68.310.09.211.45.26143
Stimulants11.628.118.511.58.910.18.78.312574
Hypnotics and sedatives8.92.82.22.43.25.010.531.24544
Hallucinogens0.90.80.10.00.00.00.20.0150
Volatile substances46.48.01.30.80.50.40.00.22010
Cannabis 21.438.518.314.013.012.511.612.715535
Other substances 2.71.62.41.92.73.02.37.72270
Total1121179208421691274774438599862924

Notes:

 : indicates data not available 

 The countries supplying data are: 

 BG, CZ, DK, DE, IE, EL, FR, CY, LV, AT, RO, SK, FI, SE, UK, HR, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2008 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Tuesday, 30 June 2009